Strantas 250Mg/5Ml Inj
₹14,600.00
Attributes
- Is Prescription Required
- Yes
- Is Returnable
- No
- Type
- Pharma
- Consume Type
- Parenteral
- Pack Size
- 5
- Cold Chain Product
- Yes
- Banned
- No
- Marketer Address
- Chinubhai Centre, Off. Nehru Bridge, Ashram Road, Ahmedabad – 380009. Gujarat. India.
- Pack Form
- Prefilled Syringe
- Product Form
- Injection
- Unit Of Measurement
- ml
- Subcategory
- Neoplastic Disorders
- Manufacturer
- INTAS PHARMACEUTICALS LTD
- Country Of Origin
- India
- Classifier 1
- NEOPLASTIC DISORDERS
- Classifier 2
- ANTI CANCER DRUGS
- Classifier 3
- ANTI CANCER DRUGS
- Restricted
- Yes
- Is Sensitive
- Yes
- Dosage Forms
- Injection
- Short Name
- Strantas 250Mg/5Ml Inj
- Unitprice
- ₹2569.6 / 1 ml
- Dpco Drug
- No
Description
Key Benefits
Strantas 250Mg/5Ml Inj contains Fulvestrant, used to treat breast cancer in postmenopausal women. Additionally, Strantas 250Mg/5Ml Inj may be used in combination with palbociclib to treat women with a type of breast cancer called hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer that is locally advanced or has spread to other parts of the body (metastatic).
Directions for Use
Strantas 250Mg/5Ml Inj will be administered by a healthcare professional; do not self-administer.
Side Effects
- Injection site reactions such as inflammation or pain
- Weakness
- Nausea
- Tiredness
- Headache
- Joint and musculoskeletal pain
Storage
Store in a cool and dry place away from sunlight
Additional information
| Is Prescription Required | |
|---|---|
| Is Returnable | |
| Type | |
| Consume Type | |
| Pack Size | |
| Cold Chain Product | |
| Banned | |
| Marketer Address | Chinubhai Centre, Off. Nehru Bridge, Ashram Road, Ahmedabad – 380009. Gujarat. India. |
| Pack Form | |
| Product Form | |
| Unit Of Measurement | |
| Subcategory | |
| Manufacturer | |
| Country Of Origin | |
| Classifier 1 | |
| Classifier 2 | |
| Classifier 3 | |
| Restricted | |
| Is Sensitive | |
| Dosage Forms | |
| Short Name | |
| Unitprice | |
| Dpco Drug |
